1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Li Junmin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations Decitabine, Arsenic Trioxide, Cytarabine - Acute Myeloid Leukemia, P53 Mutation | Phase 2 | Unknown | Li Junmin | 100 | 2018-03-01 | 2018-01-04 |
Arsenic (1) · Arsenic Trioxide (1) · Cytarabine (1) · Decitabine (1)
China (1)
Lu Min (1) · Zhang Sujiang (1)